GPT Healthcare working capital

Profitability Growth Credit Liquidity Working capital Dividend yield DuPont CAGR

Per cent unless marked ×

Tap a line for its trend	Last 12Mto Jun 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024

39.48×	39.48×	39.33×	35.88×
17.46×	17.46×	22.06×	22.15×
155.83×	155.83×	167.11×	164.49×
−98.89×	−98.89×	−105.72×	−106.46×
50.25×	48.29×	89.02×	135.71×
1.11×	1.11×	1.12×	1.16×
1.92×	1.92×	1.35×	1.44×
0.96×	0.96×	0.81×	0.78×

Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

alphave

GPTHEALTH₹136.89

GPT Healthcare Limited

· Pharma & Health

₹ CrorePeersGKSL SHALBY INDRAMEDCO LOTUSEYE ARTEMISMED DRAGARWQ KMCSHIL KOVAIMcap ₹1,123 Cr

Profitability Growth Credit Liquidity Working Capital Yield Analysis DuPont

Ratios — % unless marked × 12 Months Ending	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Inventory Days (DIO)	35.88	39.33	39.48	39.48
Receivable Days (DSO)	22.15	22.06	17.46	17.46
Payable Days (DPO)	164.49	167.11	155.83	155.83
Cash Conversion Cycle (days)	-106.46	-105.72	-98.89	-98.89
Working Capital Turnover	135.71	89.02	48.29	50.25
Asset Turnover	1.16	1.12	1.11	1.11
Cash Conversion (CFO/Net Income)	1.44	1.35	1.92	1.92
CFO/EBITDA	0.78	0.81	0.96	0.96

No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.